In December 2019, patients with pneumonia of unknown cause were diagnosed in Wuhan, China. Later, it was linked to an unknown beta coronavirus, named 2019-nCoV; after both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans.
Since its outbreak, studies have reported that respiratory symptoms, such as fever, cough, dyspnea, and respiratory illness, represent the most common symptoms (
1).
Recent studies have shown that several gastrointestinal symptoms, such as abdominal pain, diarrhea, and vomiting, can also be observed in 2019-nCOV patients (
2,
3).
Herein, we described 2 cases with unusual anastomotic leakage who were later diagnosed with COVID-19. In a 72-year-old man with a perforated peptic ulcer in D2 and signs of leakage after the first operation and during the second operation due to massive unexpected hemorrhage, we found fully disrupted anastomosis on the second part of the duodenum. Accordingly, the suture ligature of the bleeding ulcer with the closure of the duodenal stump and loop gastrojejunostomy and tube duodenostomy were performed. During the postoperative period, he developed dyspnea, and the diagnostic test of SARS-CoV-2 confirmed him as a case of COVID-19. Unfortunately, 1 week after the second surgery, evidence of anastomotic leakage appeared again by bile discharge from drains; although it was managed conservatively, he died because of respiratory failure.
In the other case, a 65-year-old woman was admitted to the emergency ward with closed-loop small bowel obstruction. After emergency laparotomy, resection of ischemic bowel with primary anastomosis was performed. The same as the previous case, she developed dyspnea, and the diagnostic test resulted positive for COVID-19. After 2 weeks, she was admitted to the hospital with signs of anastomotic leakage that was subsequently confirmed by abdominal CT; although it was managed conservatively, she died because of respiratory failure due to COVID-19.
So far, our observations and also the literature show that the coronavirus has a wide range of tissue distribution, causing the release of a high number of pro-inflammatory cytokines that damage the microvascular system and initiate an abnormal activation of the coagulation system. The result will finally be seen as small-vessel vasculitis and extensive microthrombi (
4-
6).
Microangiopathy in different organs of COVID-19 patients was reported. This problem may involve the kidney, lung, intestine, and eyes (
7-
9). To our knowledge, these cases were unique in that intestinal microangiopathies can cause very severe problems, weaken the body, and eventually death, as we have seen in these 2 cases.
In these cases, the first operation was inevitable, and the problem arose after surgery. This report shows that active COVID-19 patients should be managed differently, and surgeons should be aware of their anastomotic repair problem.
Our recommendation for an uneventful operation in COVID-19 patients is to avoid elective intestinal surgery in active COVID-19 patients, and surgery should be postponed until their symptoms resolve and IgM titer rise.
For emergency surgery in active COVID-19 patients, the surgeon should be aware of their postoperative complications, and protective measures should be taken to avoid these problems.